{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T17:29:09Z","timestamp":1794158949677,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.metabol.2024.156101","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:11:06Z","timestamp":1733771466000},"page":"156101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Prevalence, characteristics and outcomes of patients with metabolic and alcohol related\/associated liver disease (MetALD): a systematic review and meta-analysis"],"prefix":"10.1016","volume":"163","author":[{"given":"Maria","family":"Tampaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Tsochatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Lekakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Cholongitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.156101_bb0005","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156101_bb0010","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0015","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15939","article-title":"Impact of MASLD and MetALD on clinical outcomes: a meta-analysis of preliminary evidence","author":"Ciardullo","year":"2024","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.metabol.2024.156101_bb0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.metabol.2024.156101_bb0030","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/sim.4040","article-title":"Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data","volume":"29","author":"Stijnen","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.metabol.2024.156101_bb0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrica"},{"key":"10.1016\/j.metabol.2024.156101_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A","article-title":"A likelihood approach to meta-analysis with random effects","volume":"15","author":"Hardy","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.metabol.2024.156101_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2024.156101_bb0050","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"Int Hout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.metabol.2024.156101_bb0055","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"10.1016\/j.metabol.2024.156101_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"issue":"12","key":"10.1016\/j.metabol.2024.156101_bb0065","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/j.jhep.2023.08.021","article-title":"Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD","volume":"80","author":"Chen","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0070","first-page":"533","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.156101_bb0075","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/HEP.0000000000000664","article-title":"Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156101_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","article-title":"Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study","volume":"9","author":"Israelsen","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155789","article-title":"Mortality in metabolic dysfunction-associated steatotic liver disease: a nationwide population-based cohort study","volume":"152","author":"Han","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156101_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155800","article-title":"Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: a community-dwelling cohort study with 20-year follow-up","volume":"153","author":"Choe","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156101_bb0095","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/jcm13041158","article-title":"Prevalence of steatotic liver disease based on a new nomenclature in the Japanese population: a health checkup-based cross-sectional study","volume":"13","author":"Miwa","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2024.156101_bb0100","article-title":"Liver fibrosis assessed via non-invasive tests is associated with incident heart failure in a general population cohort","volume":"210","author":"Hydes","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0105","article-title":"Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2024.156101_bb0110","article-title":"Long-term risks of cirrhosis and hepatocellular carcinoma across steatotic liver disease subtypes","author":"Chen","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2024.156101_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-024-04285-w","article-title":"Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction","author":"Park","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.metabol.2024.156101_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.16552","article-title":"Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis","author":"Mori","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0125","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/apt.18015","article-title":"Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality","volume":"60","author":"Tamaki","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2024.156101_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.16554","article-title":"Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians","author":"Wu","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0140","article-title":"MASLD\/MetALD and mortality in individuals with any cardio-metabolic risk factor: a population-based study with 26.7 years of follow-up","author":"Kwak","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156101_bb0145","article-title":"ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population","volume":"6","author":"M\u00e4nnist\u00f6","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2024.156101_bb0150","series-title":"EASL Congress","article-title":"Risk of all-cause mortality and adverse outcomes from steatotic liver disease and its subgroups in the general population","volume":"2024","author":"Michel","year":"2024"},{"key":"10.1016\/j.metabol.2024.156101_bb0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0160","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/apt.17953","article-title":"Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population","volume":"59","author":"De Vincentis","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2024.156101_bb0165","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/liv.15695","article-title":"Exploring the landscape of steatotic liver disease in the general US population","volume":"43","author":"Ciardullo","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2024.156101_bb0170","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156101_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000324","article-title":"Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States","volume":"7","author":"Ochoa-Allemant","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2024.156101_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.18011","article-title":"Steatotic liver disease-associated all-cause\/cause-specific mortality in the United States","volume":"60","author":"Kim","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2024.156101_bb0185","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jhep.2023.09.014","article-title":"Metabolic dysfunction-associated steatotic liver disease and all-cause\/cause-specific mortality among adults in the United States","volume":"80","author":"Kim","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.metabol.2024.156101_bb0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/apt.17958","article-title":"Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population","volume":"59","author":"Schneider","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2024.156101_bb0200","article-title":"Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score","volume":"6","author":"Sripongpun","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2024.156101_bb0205","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.numecd.2024.05.018","article-title":"Impacts of cardiometabolic risk factors and alcohol consumption on all-cause mortality among MASLD and its subgroups","volume":"34","author":"Li","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2024.156101_bb0210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000535943","volume":"13","author":"Kim","year":"2023","journal-title":"Liver Cancer"},{"key":"10.1016\/j.metabol.2024.156101_bb0215","article-title":"Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and\/or alcohol: a nationwide study","author":"Yun","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2024.156101_bb0220","article-title":"Waitlisting and liver transplantation for MetALD in the United States: an analysis of the UNOS national registry","author":"Ochoa-Allemant","year":"2024","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.metabol.2024.156101_bb0225","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"10.1016\/j.metabol.2024.156101_bb0230","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/sim.1461","article-title":"Adjusting for publication Bias in the presence of heterogeneity","volume":"22","author":"Terrin","year":"2003","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.metabol.2024.156101_bb0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.metabol.2024.156101_bb0240","doi-asserted-by":"crossref","unstructured":"Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. J Hepatol 2018; 68:251\u2013267. d.","DOI":"10.1016\/j.jhep.2017.11.006"},{"key":"10.1016\/j.metabol.2024.156101_bb0245","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000935","article-title":"MetALD: does it require a different therapeutic option?","author":"Marek","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156101_bb0250","first-page":"S19","article-title":"Gender differences in nonalcoholic fatty liver disease","volume":"12","author":"Nagral","year":"2022","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"355","key":"10.1016\/j.metabol.2024.156101_bb0255","article-title":"Combined associations of body weight and lifestyle factors with all cause and cause specific mortality in men and women: prospective cohort study","volume":"11","author":"Veronese","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.metabol.2024.156101_bb0260","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1159\/000521662","article-title":"Clinical profiles of Asians with NAFLD: a systematic review and meta-analysis","volume":"40","author":"Kam","year":"2022","journal-title":"Dig Dis"},{"key":"10.1016\/j.metabol.2024.156101_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109924","article-title":"Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals","volume":"188","author":"Noubiap","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2024.156101_bb0270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0275","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.amjmed.2022.04.021","article-title":"Alcohol consumption and cardiovascular health","volume":"135","author":"Krittanawong","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2024.156101_bb0280","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/CIRCULATIONAHA.115.019743","article-title":"Alcohol and immediate risk of cardiovascular events: a systematic review and dose-response meta-analysis","volume":"133","author":"Mostofsky","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2024.156101_bb0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"\u00c5berg","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156101_bb0290","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clnu.2013.10.003","article-title":"Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies","volume":"33","author":"Sun","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.metabol.2024.156101_bb0295","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.6185","article-title":"Association between daily alcohol intake and risk of all-cause mortality: a systematic review and meta-analyses","volume":"6","author":"Zhao","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.metabol.2024.156101_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101643","article-title":"Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"48","author":"Bisaccia","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.metabol.2024.156101_bb0305","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156101_bb0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5551\/jat.RV22015","article-title":"Cigarette smoking and atherosclerotic cardiovascular disease","volume":"31","author":"Ishida","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.metabol.2024.156101_bb0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41569-022-00797-4","article-title":"Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes","volume":"20","author":"Regitz-Zagrosek","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2024.156101_bb0320","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1470-2045(21)00279-5","article-title":"Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study","volume":"22","author":"Rumgay","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524003299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524003299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:48:22Z","timestamp":1738975702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524003299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":64,"alternative-id":["S0026049524003299"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156101","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, characteristics and outcomes of patients with metabolic and alcohol related\/associated liver disease (MetALD): a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156101"}}